EraGen Biosciences

EraGen Biosciences

And markets molecular reagent products and software for diagnostics and research.
  • Edit
DateInvestorsAmountRound

$12.0m

Series A

$34.0m

Valuation: $34.0m

Acquisition
Total Funding$12.0m

Recent News about EraGen Biosciences

Edit